Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1145494

	registered interest
	date	24/09/2019
	answering body	Ministry of Housing, Communities and Local Government
	answering dept id	7
	answering dept short name	Housing, Communities and Local Government
	answering dept sort name	Housing, Communities and Local Government
	hansard heading	Right to Buy Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Housing, Communities and Local Government, what recent estimate his Department has made of proportion of homes purchased under the right to buy schemes that are now owned by private landlords.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	290286
	answer	answer is ministerial correction date of answer 01/10/2019 answer text <p>The Ministry of Housing, Communities and Local Government does not collect this information. Under the Right to Buy there are restrictions in place to discourage re-sale within 5 years of purchase, and mortgage providers and landlords may also place restrictions on letting in the terms of the sale.</p> answering member constituency Tatton answering member printed Esther McVey question first answered 01/10/2019 15:08:11 answering member 4084 label Biography information for Esther McVey
	tabling member	394 label Biography information for Mr Clive Betts

1145502

	registered interest
	date	24/09/2019
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	All Star Lanes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether she has commissioned an investigation into whether the Directors of All Star Lanes which went into administration should be disqualified from being company directors; and if he will make a statement.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	290290
	answer	answer is ministerial correction date of answer 03/10/2019 answer text <p>When a company enters administration, the administrator must, usually within three months, provide a confidential report to the Insolvency Service on the conduct of the directors of the company. The Insolvency Service will assess the information received and will collect information from third parties including other government departments, to determine whether or not a full investigation is required. This may ultimately lead to director disqualification proceedings or other enforcement action.</p><p>As the administration only occurred last week, the administrator’s report is not expected yet.</p> answering member constituency Rochester and Strood answering member printed Kelly Tolhurst question first answered 03/10/2019 10:04:02 answering member 4487 label Biography information for Kelly Tolhurst
	tabling member	394 label Biography information for Mr Clive Betts

1145151

	registered interest
	date	05/09/2019
	answering body	Ministry of Housing, Communities and Local Government
	answering dept id	7
	answering dept short name	Housing, Communities and Local Government
	answering dept sort name	Housing, Communities and Local Government
	hansard heading	Local Government Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Housing, Communities and Local Government, with reference to the Spending Round 2019, what the planned increase in the (a) grant to and (b) spending power of local councils for the next financial year will be in (a) real and (b) cash terms; and what estimate he has made of the increase in council tax required to achieve the spending power increase.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	287465
	answer	answer is ministerial correction date of answer 07/10/2019 answer text <p>The government recently announced the largest year-on-year real terms increase in spending power for local government in almost a decade. Core Spending Power is expected to rise by £2.9 billion from £46.2 billion to £49.1 billion in 2020-21, a cash increase of 6.3 per cent and an estimated real terms increase of 4.3 per cent.</p><p> </p><p>This includes an additional £1 billion grant for adult and children’s social care, on top of the continuation of existing social care grants. Subject to consultation and the House of Commons approving council tax referendum principles, councils will have access to an additional £1.6 billion through council tax, as part of the Local Government Finance Settlement, based on a 2 per cent core referendum principle and a 2 per cent adult social care precep</p> answering member constituency Thornbury and Yate answering member printed Luke Hall question first answered 07/10/2019 15:37:25 answering member 4450 label Biography information for Luke Hall
	tabling member	394 label Biography information for Mr Clive Betts

1135182

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which diagnostic tests will whole genome sequencing replace, particularly for blood cancers.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	270281
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270282 270283 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1135183

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genetics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the National Genomic Test Directory directly replaces the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	270282
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270281 270283 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1135184

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how will new tests be added to the National Genomic Test Directory.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	270283
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270281 270282 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1132282

	registered interest
	date	14/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients that will benefit from whole genome sequencing in the first year of its introduction; and what steps is he taking to ensure the adequacy of trained professionals to provide that service.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	264725
	answer	answer is ministerial correction date of answer 19/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test;</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 19/06/2019 16:17:13 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1132005

	registered interest
	date	13/06/2019
	answering body	Ministry of Housing, Communities and Local Government
	answering dept id	7
	answering dept short name	Housing, Communities and Local Government
	answering dept sort name	Housing, Communities and Local Government
	hansard heading	Local Government: Audit
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Housing, Communities and Local Government, what assessment he has made of the implications for his policies of the failure of EY to complete local authority audits within the required time limits.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	264322
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>We are aware of this issue, affecting 19 local government bodies and, together with Public Sector Audit Appointments Ltd, are monitoring the situation. It is not acceptable for a professional services firm like EY to be unable to meet its contractual obligations to the statutory timetable and we expect the situation to be resolved as quickly as possible.</p><p>The forthcoming review of the local audit regime will consider the implications of our audit policy, including the timeliness of audit completion.</p> answering member constituency Richmond (Yorks) answering member printed Rishi Sunak question first answered 18/06/2019 13:27:52 answering member 4483 label Biography information for Rishi Sunak
	tabling member	394 label Biography information for Mr Clive Betts

1132006

	registered interest
	date	13/06/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Charter Flights: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, pursuant to the Answer of 8 May 2019 to Question 249823, Civil Aviation Authority, what recent estimate he has made of the scale of unlawful passenger transport operations.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	264323
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The CAA, as the independent safety regulator, has not made an estimate of the scale of unlawful passenger transport operations.</p><p> </p><p>There are strict rules in place that require commercial air transport operations to be operated by the holder of an Air Operator Certificate (AOC) and an Operating Licence (OL). It is an offence to operate a commercial air transport flight without an AOC or OL.</p><p> </p><p>Since 2016, the CAA’s investigations and enforcement team has received 21 allegations of illegal public transport. The CAA investigates such allegations and will prosecute people where there is sufficient evidence, and where it is in the public interest to do so. The CAA also conducts spot check visits to airfields and public events where aeroplane and helicopter operations take place, and where it finds evidence that a flight may have operated illegally it has the power to detain an aircraft and, where appropriate, take enforcement action.</p> answering member constituency Northampton North answering member printed Michael Ellis question first answered 18/06/2019 11:18:40 answering member 4116 label Biography information for Sir Michael Ellis
	tabling member	394 label Biography information for Mr Clive Betts

1132007

	registered interest
	date	13/06/2019
	answering body	Department for International Trade
	answering dept id	202
	answering dept short name	International Trade
	answering dept sort name	International Trade
	hansard heading	BeoutQ
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for International Trade, pursuant to the Answer of 8 April to Question 239902 on Saudi Arabia: Sports, Question 239903 on BeoutQ and Question 239904 on BeoutQ , what steps the Saudi Arabian Government has agreed to take as a result of those representations.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	264324
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>HM Government Ministers and HM Ambassador in Riyadh continue to make representations on beoutQ and the Saudi Arabian Government has confirmed they are looking into the matter.</p> answering member constituency Beverley and Holderness answering member printed Graham Stuart question first answered 18/06/2019 15:07:47 answering member 1482 label Biography information for Graham Stuart
	tabling member	394 label Biography information for Mr Clive Betts